# Treatment of Ptosis to Muscular Dystrophy Oculopharyngeal by Myoblast Autologous Graft

> **NCT02878694** · PHASE2,PHASE3 · TERMINATED · sponsor: **University Hospital, Caen** · enrollment: 1 (actual)

## Conditions studied

- Muscular Dystrophy, Oculopharyngeal
- Ptosis

## Interventions

- **BIOLOGICAL:** Myoblast autologous graft

## Key facts

- **NCT ID:** NCT02878694
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-11-14
- **Primary completion:** 2020-10-09
- **Final completion:** 2020-10-09
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** insufficient recruitment
- **Last updated:** 2020-11-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02878694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02878694, "Treatment of Ptosis to Muscular Dystrophy Oculopharyngeal by Myoblast Autologous Graft". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02878694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*